Summary
GlobalData's clinical trial report, “Gaucher Disease Global Clinical Trials Review, H1, 2016" provides an overview of Gaucher Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Sanofi
Protalix BioTherapeutics, Inc.
Shire Plc
Amicus Therapeutics, Inc.
Zywie, LLC
Belrose Pharma Inc.
ISU Chemical Co., Ltd.
Actelion Ltd
Quintiles Transnational Holdings Inc.
Jaguar Holding Company II
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Gaucher Disease to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Gaucher Disease to Genetic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Gaucher Disease Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84
List of Tables
Gaucher Disease Therapeutics, Global, Clinical Trials by Region, 2016* 6
Gaucher Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Gaucher Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Gaucher Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Gaucher Disease Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Gaucher Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Gaucher Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 15
Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, E7 Countries (%), 2016* 18
Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Gaucher Disease Therapeutics, Global, Clinical Trials by Phase, 2016* 21
Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
Gaucher Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Gaucher Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Gaucher Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Gaucher Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
Gaucher Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Gaucher Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Gaucher Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
List of Figures
Gaucher Disease Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Gaucher Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Gaucher Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Gaucher Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Gaucher Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Gaucher Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Gaucher Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 15
Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, E7 Countries (%), 2016* 18
Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Gaucher Disease Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
Gaucher Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Gaucher Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Gaucher Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Gaucher Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
Gaucher Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Gaucher Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Gaucher Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
GlobalData Methodology 82
